April 23, 2018 / 9:54 PM / 7 months ago

BRIEF-Onconova Says As Of April 13, Co Was Not Able To Regain Compliance With Continued Listing Requirements Of Nasdaq Capital Market

April 23 (Reuters) - Onconova Therapeutics Inc:

* ONCONOVA SAYS AS OF APRIL 13, 2018, CO WAS NOT ABLE TO REGAIN COMPLIANCE WITH CONTINUED LISTING REQUIREMENTS OF NASDAQ CAPITAL MARKET - SEC FILING

* ONCONOVA - ON APRIL 23, RECEIVED LETTER FROM NASDAQ HEARINGS PANEL STATING PANEL HAS GRANTED CO AN EXTENSION TO MAY 14, 2018 TO REGAIN COMPLIANCE Source text: (bit.ly/2Fbcdu8) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below